Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta

Total Page:16

File Type:pdf, Size:1020Kb

Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta International Journal of Molecular Sciences Article Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta Pierre Moffatt 1,2 , Iris Boraschi-Diaz 1,3, Juliana Marulanda 1,3, Ghalib Bardai 1 and Frank Rauch 1,3,* 1 Shriners Hospital for Children-Canada, Montreal, QC H4A 0A9, Canada; [email protected] (P.M.); [email protected] (I.B.-D.); [email protected] (J.M.); [email protected] (G.B.) 2 Department of Pediatrics, McGill University, Montreal, QC H4A 3J1, Canada 3 Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada * Correspondence: [email protected]; Tel.: +1-514-282-7193 Abstract: Osteogenesis imperfecta (OI) is a bone fragility disorder that is usually caused by mutations affecting collagen type I. We compared the calvaria bone tissue transcriptome of male 10-week-old heterozygous Jrt (Col1a1 mutation) and homozygous oim mice (Col1a2 mutation) to their respec- tive littermate results. We found that Jrt and oim mice shared 185 differentially expressed genes (upregulated: 106 genes; downregulated: 79 genes). A total of seven genes were upregulated by a factor of two or more in both mouse models (Cyp2e1, Slc13a5, Cgref1, Smpd3, Ifitm5, Cthrc1 and Rerg). One gene (Gypa, coding for a blood group antigen) was downregulated by a factor of two or more in both OI mouse models. Overrepresentation analyses revealed that genes involved in ‘ossification’ were significantly overrepresented among upregulated genes in both Jrt and oim mice, whereas hematopoietic genes were downregulated. Several genes involved in Wnt signaling and transforming growth factor beta signaling were upregulated in oim mice, but less so in Jrt mice. Thus, Citation: Moffatt, P.; Boraschi-Diaz, this study identified a set of genes that are dysregulated across various OI mouse models and are I.; Marulanda, J.; Bardai, G.; Rauch, F. likely to play an important role in the pathophysiology of this disorder. Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Keywords: osteogenesis imperfecta; RNA sequencing; transforming growth factor beta; Imperfecta. Int. J. Mol. Sci. 2021, 22, Wnt signaling 5290. https://doi.org/10.3390/ ijms22105290 Academic Editor: Alberto Falchetti 1. Introduction Osteogenesis imperfecta (OI) is a heritable connective tissue disorder that is clinically Received: 7 April 2021 characterized by low bone mass, bone fragility, long bone deformity, scoliosis, discolored Accepted: 12 May 2021 Published: 18 May 2021 sclera and dentinogenesis imperfecta [1]. In the large majority of individuals with OI, the condition is caused by mutations in Col1a1 or Col1a2 that directly affect the bone matrix Publisher’s Note: MDPI stays neutral protein collagen type I [2]. However, pathogenic variants in about 20 other genes can also with regard to jurisdictional claims in give rise to an OI phenotype [1]. published maps and institutional affil- How mutations in Col1a1 and Col1a2 lead to low bone mass and bone fragility is iations. not entirely clear. The low bone mass of OI is not simply caused by an inability of the osteoblast system to produce bone. Indeed, many children with severe OI have increased bone formation rates, as shown by iliac bone histomorphometry [3,4]. Low bone mass in OI is therefore likely caused by dysregulation of bone cell activity rather than the incapacity of osteoblasts to produce enough organic bone matrix. Copyright: © 2021 by the authors. Several mouse models with mutations in Col1a1 or Col1a2 are available to study Licensee MDPI, Basel, Switzerland. This article is an open access article the dysregulation of bone cells. A widely used model is the oim mouse that harbors a distributed under the terms and frameshift mutation in Col1a2 [5]. Homozygous oim mice are small and have spontaneous conditions of the Creative Commons fractures, mimicking the manifestations of severe OI in humans. The Jrt mouse is a model Attribution (CC BY) license (https:// of dominant severe OI caused by a splice-site mutation in Col1a1 that leads to an 18-amino creativecommons.org/licenses/by/ acid deletion in the collagen type I alpha 1 chain [6]. Similar to the homozygous oim mouse, 4.0/). the heterozygous Jrt mouse has spontaneous fractures and bone deformities. Int. J. Mol. Sci. 2021, 22, 5290. https://doi.org/10.3390/ijms22105290 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x 2 of 12 Int. J. Mol. Sci. 2021, 22, 5290 2 of 12 acid deletion in the collagen type I alpha 1 chain [6]. Similar to the homozygous oim mouse, the heterozygous Jrt mouse has spontaneous fractures and bone deformities. Thus,Thus, homozygous homozygous oimoim micemice and and heterozygous heterozygous Jrt Jrt mice mice harbor harbor quite quite different different muta- muta- tionstions in in Col1a2Col1a2 andand Col1a1Col1a1,, respectively, butbut shareshare a a similarly similarly severe severe phenotype. phenotype. Identifying Identify- ingmolecular molecular pathways pathways and genesand genes that arethat dysregulated are dysregulated in both in mouse both modelsmouse mightmodels therefore might thereforehelp to delineate help to delineate common common factors that factors are involvedthat are involved in causing in lowcausing bone low mass bone and mass bone andfragility bone infragility the context in the ofcontext mutations of mutations in collagen in collagen type I encoding type I encoding genes. Ingenes. the presentIn the presentstudy, westudy therefore, we therefore performed performed RNA sequencing RNA sequencing in the calvaria in the bone calvaria tissues bone of homozygous tissues of homozygousoim and heterozygous oim and heterozygous Jrt mice and performedJrt mice and differential performed gene differential expression gene analyses. expression We analyses.identified We a setidentified of genes a set that of aregenes dysregulated that are dysregulated across various across OI various mouse OI models mouse and mod- are elslikely and toare play likely an to important play an important role in the role pathophysiology in the pathophysiology of this disorder. of this disorder. 2.2. Results Results ComparedCompared to to wild wild type type (WT) (WT) mice, mice, 231 231 genes genes were were differentially differentially expressed expressed in in Jrt Jrt micemice,, and and 2969 2969 genes genes were were differentially differentially expressed expressed in oim in oim micemice (Figure (Figure 1). 1We). Wefound found 185 genes185 genes that were that differentially were differentially expressed expressed in both inJrt bothand oim Jrt andmice,oim whmice,ich were which all concord- were all antlyconcordantly upregulated upregulated (106 genes) (106 or downregulated genes) or downregulated (79 genes) between (79 genes) the two between models the (Sup- two plementarymodels (Supplementary Tables S1–S6) Tables. S1–S6). FigureFigure 1. 1. ResultsResults of of RNA RNA sequencing sequencing in in calvaria calvaria of of 10 10-week-old-week-old mice. Venn diagramdiagram ofof differentiallydifferen- tiallyexpressed expressed genes genes in oim inand oim Jrtand mice. Jrt mice. TheThe list list of of the the top top 20 20 upregulated upregulated genes genes in in Jrt Jrt mice mice contained contained genes genes that that are are known known toto be be important important for for the the osteoblast osteoblast function function (e.g., (e.g., BglapBglap——thethe gene gene coding coding for for osteocalcin; osteocalcin; Ifitm5Ifitm5——codingcoding for for BRIL) BRIL) and and the the synthesis synthesis of of extracellular extracellular matrix matrix (Smpd3 (Smpd3, ,Col11a1Col11a1, ,Col11a2Col11a2 andand Adamts14Adamts14) )(Table (Table 11).). TableTable 1. 1. ListList of of the the top top 20 20 upregulated upregulated genes in Jrt mice compared toto WTWT mice.mice. pp valuesvalues areare adjustedad- justedby the by Benjamini–Hochberg the Benjamini–Hochberg procedure, procedure, as determined as determined by deseq2. by deseq2. Fold GeneGene DescriptionDescription Fold Change pp Change Cyp2e1 Cytochrome P450, family 2, subfamily e, polypeptide 1 4.25 0.009 Cyp2e1 Cytochrome P450, family 2, subfamily e, polypeptide 1 4.25 0.009 BglapBglap BoneBone gamma gamma carboxyglutamate carboxyglutamate protein protein 3.443.44 <0.001<0.001 Bglap2Bglap2 BoneBone gamma-carboxyglutamate gamma-carboxyglutamate protein protein 2 2 3.143.14 <0.001<0.001 Cyp2f2Cyp2f2 CytochromeCytochrome P450, P450, family family 2, subfamily 2, subfamily f, polypeptide f, polypeptide 2 2 2.902.90 <0.001<0.001 Ighg2c 2.87 0.02 Ighg2c 2.87 0.02 Slc13a5 Solute carrier family 13, member 5 2.59 <0.001 Slc13a5Creb3l3 cAMPSolute responsive carrier family element 13, memberbinding protein 5 3-like 3 2.592.55 <0.0010.003 Creb3l3Tpsb2 cAMP responsive elementTryptase binding beta protein 2 3-like 3 2.552.38 0.0030.003 Col11a1Tpsb2 TryptaseCollagen, beta type 2 XI, alpha 1 2.382.34 0.0030.006 Col11a2 Collagen, type XI, alpha 2 2.31 0.015 Col11a1 Collagen, type XI, alpha 1 2.34 0.006 Lipc Lipase, hepatic 2.30 <0.001 Col11a2 Collagen, type XI, alpha 2 2.31 0.015 Lipc Lipase, hepatic 2.30 <0.001 Int. J. Mol. Sci. 2021, 22, 5290 3 of 12 Table 1. Cont. Gene Description Fold Change p Cgref1 Cell growth regulator with EF hand domain 1 2.29 <0.001 Ifi27l2a Interferon, alpha-inducible protein 27 like 2A 2.24 <0.001 Smpd3 Sphingomyelin phosphodiesterase 3, neutral 2.22 <0.001 Ifitm5 Interferon induced transmembrane protein 5 2.19 <0.001 Ctsw Cathepsin W 2.14 0.04 Kazald1 Kazal-type serine peptidase inhibitor domain 1 2.14 <0.001 Cthrc1 Collagen triple helix repeat containing 1 2.05 <0.001 Rerg RAS-like, estrogen-regulated, growth-inhibitor 2.05 0.002 A disintegrin-like and metallopeptidase with Adamts14 1.98 <0.001 thrombospondin type 1 motif, 14 In oim mice, the list of the top 20 upregulated genes also contained genes that play a role in the function of osteoblasts (e.g., Edn1, Ddit4, Cdkn1a, Igfbp3 and Stc2) (Table2). Only one gene (Cyp2e1) was among the top 20 upregulated genes in both Jrt and oim mice.
Recommended publications
  • Development and Maintenance of Epidermal Stem Cells in Skin Adnexa
    International Journal of Molecular Sciences Review Development and Maintenance of Epidermal Stem Cells in Skin Adnexa Jaroslav Mokry * and Rishikaysh Pisal Medical Faculty, Charles University, 500 03 Hradec Kralove, Czech Republic; [email protected] * Correspondence: [email protected] Received: 30 October 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: The skin surface is modified by numerous appendages. These structures arise from epithelial stem cells (SCs) through the induction of epidermal placodes as a result of local signalling interplay with mesenchymal cells based on the Wnt–(Dkk4)–Eda–Shh cascade. Slight modifications of the cascade, with the participation of antagonistic signalling, decide whether multipotent epidermal SCs develop in interfollicular epidermis, scales, hair/feather follicles, nails or skin glands. This review describes the roles of epidermal SCs in the development of skin adnexa and interfollicular epidermis, as well as their maintenance. Each skin structure arises from distinct pools of epidermal SCs that are harboured in specific but different niches that control SC behaviour. Such relationships explain differences in marker and gene expression patterns between particular SC subsets. The activity of well-compartmentalized epidermal SCs is orchestrated with that of other skin cells not only along the hair cycle but also in the course of skin regeneration following injury. This review highlights several membrane markers, cytoplasmic proteins and transcription factors associated with epidermal SCs. Keywords: stem cell; epidermal placode; skin adnexa; signalling; hair pigmentation; markers; keratins 1. Epidermal Stem Cells as Units of Development 1.1. Development of the Epidermis and Placode Formation The embryonic skin at very early stages of development is covered by a surface ectoderm that is a precursor to the epidermis and its multiple derivatives.
    [Show full text]
  • Id Proteins Promote a Cancer Stem Cell Phenotype in Triple Negative Breast
    bioRxiv preprint doi: https://doi.org/10.1101/497313; this version posted March 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Id proteins promote a cancer stem cell phenotype in triple negative 2 breast cancer via negative regulation of Robo1 3 Wee S. Teo1,2, Holly Holliday1,2#, Nitheesh Karthikeyan3#, Aurélie S. Cazet1,2, Daniel L. 4 Roden1,2, Kate Harvey1, Christina Valbirk Konrad1, Reshma Murali3, Binitha Anu Varghese3, 5 Archana P. T.3,4, Chia-Ling Chan1,2, Andrea McFarland1, Simon Junankar1,2, Sunny Ye1, 6 Jessica Yang1, Iva Nikolic1,2, Jaynish S. Shah5, Laura A. Baker1,2, Ewan K.A. Millar1,6,7,8, 7 Mathew J. Naylor1,2,10, Christopher J. Ormandy1,2, Sunil R. Lakhani11, Warren Kaplan1,12, 8 Albert S. Mellick13,14, Sandra A. O’Toole1,9, Alexander Swarbrick1,2*, Radhika Nair1,2,3* 9 Affiliations 10 1Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia 11 2St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, New South Wales, 12 Australia 13 3 Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Kerala, India 14 4Manipal Academy of Higher Education, Manipal, Karnataka, India 15 5Centenary Institute, The University of Sydney, New South Wales, Australia 16 6 Department of Anatomical Pathology, NSW Health Pathology, St George Hospital, 17 Kogarah, NSW, Australia 18 7 School of Medical Sciences, UNSW Sydney, Kensington NSW, Australia.
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Gene Pval Qval Log2 Fold Change AAMP 0.895690332 0.952598834
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut Gene pval qval Log2 Fold Change AAMP 0.895690332 0.952598834 -0.21 ABI3BP 0.002302151 0.020612283 0.465 ACHE 0.103542461 0.296385483 -0.16 ACTG2 2.99E-07 7.68E-05 3.195 ACVR1 0.071431098 0.224504378 0.19 ACVR1C 0.978209579 0.995008423 0.14 ACVRL1 0.006747504 0.042938663 0.235 ADAM15 0.158715519 0.380719469 0.285 ADAM17 0.978208929 0.995008423 -0.05 ADAM28 0.038932876 0.152174187 -0.62 ADAM8 0.622964796 0.790251882 0.085 ADAM9 0.122003358 0.329623107 0.25 ADAMTS1 0.180766659 0.414256926 0.23 ADAMTS12 0.009902195 0.05703885 0.425 ADAMTS8 4.60E-05 0.001169089 1.61 ADAP1 0.269811968 0.519388039 0.075 ADD1 0.233702809 0.487695826 0.11 ADM2 0.012213453 0.066227879 -0.36 ADRA2B 0.822777921 0.915518785 0.16 AEBP1 0.010738542 0.06035531 0.465 AGGF1 0.117946691 0.320915024 -0.095 AGR2 0.529860903 0.736120272 0.08 AGRN 0.85693743 0.928047568 -0.16 AGT 0.006849995 0.043233572 1.02 AHNAK 0.006519543 0.042542779 0.605 AKAP12 0.001747074 0.016405449 0.51 AKAP2 0.409929603 0.665919397 0.05 AKT1 0.95208288 0.985354963 -0.085 AKT2 0.367391504 0.620376005 0.055 AKT3 0.253556844 0.501934205 0.07 ALB 0.064833867 0.21195036 -0.315 ALDOA 0.83128831 0.918352939 0.08 ALOX5 0.029954404 0.125352668 -0.3 AMH 0.784746815 0.895196237 -0.03 ANG 0.050500474 0.181732067 0.255 ANGPT1 0.281853305 0.538528647 0.285 ANGPT2 0.43147281 0.675272487 -0.15 ANGPTL2 0.001368876 0.013688762 0.71 ANGPTL4 0.686032669 0.831882134 -0.175 ANPEP 0.019103243 0.089148466 -0.57 ANXA2P2 0.412553021 0.665966092 0.11 AP1M2 0.87843088 0.944681253 -0.045 APC 0.267444505 0.516134751 0.09 APOD 1.04E-05 0.000587404 0.985 APOE 0.023722987 0.104981036 -0.395 APOH 0.336334555 0.602273505 -0.065 Sundar R, et al.
    [Show full text]
  • R&D Assay for Alzheimer's Disease
    R&DR&D assayassay forfor Alzheimer’sAlzheimer’s diseasedisease Target screening⳼ Ⲽ㬔 antibody array, ᢜ⭉㬔 ⸽ἐⴐ Amyloid β-peptide Alzheimer’s disease⯸ ኸᷠ᧔ ᆹ⸽ inhibitor, antibody, ELISA kit Surwhrph#Surilohu#Dqwlerg|#Duud| 6OUSFBUFE 1."5SFBUFE )41 $3&# &3, &3, )41 $3&# &3, &3, 壤伡庰䋸TBNQMF ɅH 侴䋸嵄䍴䋸BOBMZUFT䋸䬱娴哜塵 1$ 1$ 1$ 1$ 5IFNPTUSFGFSFODFEBSSBZT 1$ 1$ QQ α 34, .4, 503 Q α 34, .4, 503 %SVHTDSFFOJOH0òUBSHFUFòFDUT0ATHWAY涭廐 6OUSFBUFE 堄币䋸4BNQMF侴䋸8FTUFSOPS&-*4"䍘䧽 1."5SFBUFE P 8FTUFSOCMPU廽喜儤应侴䋸0, Z 4VCTUSBUF -JHIU )31DPOKVHBUFE1BO "OUJQIPTQIPUZSPTJOF .FBO1JYFM%FOTJUZ Y $BQUVSF"OUJCPEZ 5BSHFU"OBMZUF "SSBZ.FNCSBOF $3&# &3, &3, )41 .4, Q α 34, 503 Human XL Cytokine Array kit (ARY022, 102 analytes) Adiponectin,Aggrecan,Angiogenin,Angiopoietin-1,Angiopoietin-2,BAFF,BDNF,Complement,Component C5/C5a,CD14,CD30,CD40L, Chitinase 3-like 1,Complement Factor D,C-Reactive Protein,Cripto-1,Cystatin C,Dkk-1,DPPIV,EGF,EMMPRIN,ENA-78,Endoglin, Fas L,FGF basic,FGF- 7,FGF-19,Flt-3 L,G-CSF,GDF-15,GM-CSF,GRO-α,Grow th Hormone,HGF,ICAM-1,IFN-γ,IGFBP-2,IGFBP-3, IL-1α,IL-1β, IL-1ra,IL-2,IL-3,IL-4,IL- 5,IL-6,IL-8, IL-10,IL-11,IL-12, IL-13,IL-15,IL-16,IL-17A,IL-18 BPa,IL-19,IL-22, IL-23,IL-24,IL-27, IL-31,IL-32α/β/γ,IL-33,IL-34,IP-10,I-TAC,Kallikrein 3,Leptin,LIF,Lipocalin-2,MCP-1,MCP-3,M-CSF,MIF,MIG,MIP-1α/MIP-1β,MIP-3α,MIP-3β,MMP-9, Myeloperoxidase,Osteopontin, p70, PDGF-AA, PDGF-AB/BB,Pentraxin-3, PF4, RAGE, RANTES,RBP4,Relaxin-2, Resistin,SDF-1α,Serpin E1, SHBG, ST2, TARC,TFF3,TfR,TGF- ,Thrombospondin-1,TNF-α, uPAR, VEGF, Vitamin D BP Human Protease (34 analytes) /
    [Show full text]
  • Morfofunctional Structure of the Skull
    N.L. Svintsytska V.H. Hryn Morfofunctional structure of the skull Study guide Poltava 2016 Ministry of Public Health of Ukraine Public Institution «Central Methodological Office for Higher Medical Education of MPH of Ukraine» Higher State Educational Establishment of Ukraine «Ukranian Medical Stomatological Academy» N.L. Svintsytska, V.H. Hryn Morfofunctional structure of the skull Study guide Poltava 2016 2 LBC 28.706 UDC 611.714/716 S 24 «Recommended by the Ministry of Health of Ukraine as textbook for English- speaking students of higher educational institutions of the MPH of Ukraine» (minutes of the meeting of the Commission for the organization of training and methodical literature for the persons enrolled in higher medical (pharmaceutical) educational establishments of postgraduate education MPH of Ukraine, from 02.06.2016 №2). Letter of the MPH of Ukraine of 11.07.2016 № 08.01-30/17321 Composed by: N.L. Svintsytska, Associate Professor at the Department of Human Anatomy of Higher State Educational Establishment of Ukraine «Ukrainian Medical Stomatological Academy», PhD in Medicine, Associate Professor V.H. Hryn, Associate Professor at the Department of Human Anatomy of Higher State Educational Establishment of Ukraine «Ukrainian Medical Stomatological Academy», PhD in Medicine, Associate Professor This textbook is intended for undergraduate, postgraduate students and continuing education of health care professionals in a variety of clinical disciplines (medicine, pediatrics, dentistry) as it includes the basic concepts of human anatomy of the skull in adults and newborns. Rewiewed by: O.M. Slobodian, Head of the Department of Anatomy, Topographic Anatomy and Operative Surgery of Higher State Educational Establishment of Ukraine «Bukovinian State Medical University», Doctor of Medical Sciences, Professor M.V.
    [Show full text]
  • Inhibition of MEPE Cleavage by Phex
    _________________________________________________________________________http://www.paper.edu.cn BBRC Biochemical and Biophysical Research Communications 297 (2002) 38–45 www.academicpress.com Inhibition of MEPE cleavage by Phex Rong Guo,a Peter S.N. Rowe,b Shiguang Liu,a Leigh G. Simpson,a Zhou-Sheng Xiao,a and L. Darryl Quarlesa,* a Department of Medicine, The Center for Bone and Mineral Disorders, Duke University Medical Center, Box 3036, Durham, NC 27710, USA b The University of Texas Health Science Center at San Antonio, Institute for Drug Development, Molecular Therapies, Endocrinology, Texas Research Park, 14960 Omicron Drive, 78245 San Antonio, TX, USA Received 7 August 2002 Abstract X-linked hypophosphatemia (XLH) and the Hyp-mouse disease homolog are caused by inactivating mutations of Phex which results in the local accumulation of an unknown autocrine/paracrine factor in bone that inhibits mineralization of extracellular matrix. In these studies, we evaluated whether the matrix phosphoglycoprotein MEPE, which is increased in calvaria from Hyp mice, is a substrate for Phex. Using recombinant full-length Phex (rPhexWT) produced in Sf9 cells, we failed to observe Phex- dependent hydrolysis of recombinant human MEPE (rMEPE). Rather, we found that rPhex-WT inhibited cleavage of rMEPE by endogenous cathepsin-like enzyme activity present in Sf9 membrane. Sf9 membranes as well as purified cathepsin B cleaved MEPE into two major fragments of 50 and 42 kDa. rPhexWT protein in Sf9 membrane fractions, co-incubation of rPhexWT and cathepsin B, and pre-treatment of Sf9 membranes with leupeptin prevented the hydrolysis of MEPE in vitro. The C-terminal domain of Phex was required for inhibition of MEPE cleavage, since the C-terminal deletion mutant rPhex (1–433) [rPhex30M] failed to inhibit Sf9-dependent metabolism of MEPE.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • Osteoactivin and Cd44 : a Novel Interaction Regulating Bone Cell Differentiation and Function
    OSTEOACTIVIN AND CD44 : A NOVEL INTERACTION REGULATING BONE CELL DIFFERENTIATION AND FUNCTION A dissertation submitted to Kent State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy by Gregory R. Sondag December 2015 © Copyright All rights reserved Except for previously published materials Dissertation written by Gregory R. Sondag B.S., Edinboro Univeristy of Pennsylvania, Edinboro, PA, USA 2010 M.S., Edinboro Univeristy of Pennsylvania, Edinboro, PA, USA 2011 Approved by Fayez Safadi___________________, Chair, Doctoral Dissertation Committee Walt Horton Jr.___________ ______, Members, Doctoral Dissertation Committee James Hardwick ________________, Werner Geldenhuys _____________, Min-Ho Kim __________________ _, Richard Meindl__________________, Accepted by Ernest Freeman_________________, Director, School of Biomedical Sciences James L. Blank__________________, Dean, College of Arts and Sciences TABLE OF CONTENTS TABLE OF CONTENTS ...................................................................................... III LIST OF FIGURES............................................................................................. VII LIST OF TABLES ............................................................................................ XIII LIST OF ABBREVIATIONS .............................................................................. XIV DEDICATION ..................................................................................................... XV ACKNOWLEDGEMENTS ................................................................................
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • Comparative Transcriptome Analyses Reveal Genes Associated with SARS-Cov-2 Infection of Human Lung Epithelial Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.24.169268; this version posted June 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells Darshan S. Chandrashekar1, *, Upender Manne1,2,#, Sooryanarayana Varambally1,2,3,#* 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 2Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 3Institute of Informatics, University of Alabama at Birmingham, Birmingham, AL # Share Senior Authorship (UM Email: [email protected]) *Correspondence to: Sooryanarayana Varambally, Ph.D., Molecular and Cellular Pathology, Department of Pathology, Wallace Tumor Institute, 4th floor, 20B, University of Alabama at Birmingham, Birmingham, AL 35233, USA Phone: (205) 996-1654 Email: [email protected] And Darshan S. Chandrashekar Ph.D., Department of Pathology, University of Alabama at Birmingham, Birmingham, AL Email: [email protected] Running Title: SARS-CoV-2 gene signature in infected lung epithelial cells Disclosure of Potential Conflicts of Interest: No potential conflicts of interest were disclosed. Page | 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.24.169268; this version posted June 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract: Understanding the molecular mechanism of SARS-CoV-2 infection (the cause of COVID-19) is a scientific priority for 2020. Various research groups are working toward development of vaccines and drugs, and many have published genomic and transcriptomic data related to this viral infection.
    [Show full text]